V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330008520 | 330011890 | 0 | null | Curative (C) | 2014-01-24 | 2014-01-24 | EW EuroEwing 99 : VActI | N | N | 330019369 | EURO-EWING |
| 330008521 | 330005314 | null | 77 | Neo-adjuvant (N) | 2016-05-04 | 2016-08-02 | Cyclophosphamide + Topotecan | N | N | 330019378 | VINBLASTINE |
| 330008522 | 330005314 | 1.58 | 61.2 | Curative (C) | 2018-01-25 | 2018-01-31 | GemCarbo Days 1+8 | N | N | 330019378 | GEMCARBO |
| 330008523 | 330005315 | null | 55 | Palliative (P) | null | 2014-07-02 | Vinblastine | null | null | 330019454 | CAV |
| 330008524 | 330010824 | 1.77 | 67.5 | Palliative (P) | 2017-03-01 | 2017-04-11 | Methotrexate intrathecal | N | N | 330019459 | METHOTREXATE INTRATHECAL |
| 330008525 | 330012508 | 1.78 | 49.9 | Palliative (P) | 2016-03-23 | 2016-03-27 | Docetaxel 75mg/m2 (21 day) | 02 | N | 330019465 | DOCETAXEL |
| 330008527 | 330008897 | 1.67 | null | Curative (C) | 2016-09-09 | 2016-09-21 | Etoposide oral | 2 | N | 330019485 | ETOPOSIDE |
| 330008528 | 330008897 | null | 62.4 | Neo-adjuvant (N) | 2017-01-22 | 2017-01-22 | Vinblastine | 02 | N | 330019485 | TEMOZOLOMIDE |
| 330008529 | 330005317 | 1.73 | null | Palliative (P) | 2013-02-12 | 2013-02-14 | CISPLATIN + ETOPOSIDE | null | null | 330019489 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 330008530 | 330005317 | 1.62 | 59.1 | Curative (C) | null | 2016-07-06 | Cyclophosphamide + Dex + Rituximab | null | null | 330019489 | TEMOZOLOMIDE |
| 330008532 | 330005319 | null | 78.7 | Palliative (P) | 2015-03-02 | 2015-03-04 | Liposomal Doxorubicin (Caelyx) | 2 | N | 330019510 | LIPOSOMAL DOXORUBICIN |
| 330008533 | 330005320 | 1.76 | 114 | Curative (C) | 2013-11-20 | 2014-01-03 | Cyclophosphamide + Dex + Rituximab | null | null | 330019510 | AZACITIDINE |
| 330008534 | 330011894 | null | 100.3 | Curative (C) | 2016-09-09 | 2017-01-14 | ETOPOSIDE | N | N | 330019528 | ETOPOSIDE |
| 330008535 | 330013260 | 1.67 | 75.6 | Neo-adjuvant (N) | 2017-02-03 | 2017-03-04 | Trabectedin | N | Y | 330019529 | TRABECTEDIN |
| 330008538 | 330005324 | 1.6 | 51.9 | Adjuvant (A) | 2013-03-27 | 2013-03-28 | Cytarabine High Dose | 2 | N | 330019584 | CYTARABINE HIGH DOSE |
| 330008540 | 330008904 | 0 | 28.1 | null | 2015-06-19 | 2015-06-25 | CYCLOPHOSPHAMIDE + RITUXIMAB | 02 | N | 330019610 | CISPLATIN + ETOPOSIDE |
| 330008541 | 330008905 | 1.5 | null | Curative (C) | 2013-05-18 | 2013-05-20 | Irinotecan + Temozolomide | 2 | N | 330019611 | IRINOTECAN + TEMOZOLOMIDE |
| 330008543 | 330005332 | 1.67 | 103.4 | Curative (C) | 2017-08-20 | 2017-08-30 | FLAG + Idarubicin | null | null | 330019614 | FLAG + IDARUBICIN |
| 330008544 | 330005332 | 1.82 | 51 | Palliative (P) | 2017-03-29 | 2017-04-18 | ETOPOSIDE | 2 | N | 330019614 | ETOPOSIDE |
| 330008545 | 330005333 | null | 77.5 | Palliative (P) | 2014-12-19 | 2014-12-20 | Cytarabine High Dose | N | N | 330019624 | CYTARABINE HIGH DOSE |
| 330008546 | 330005337 | null | 94.7 | Disease modification (D) | 2016-08-13 | 2016-09-02 | Methotrexate intrathecal | null | null | 330019626 | METHOTREXATE INTRATHECAL |
| 330008547 | 330010831 | 1.8 | 85.4 | Curative (C) | 2015-09-29 | 2015-10-08 | NIVOLUMAB | N | N | 330019626 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330008548 | 330011897 | 1.79 | 74.25 | Palliative (P) | 2017-12-31 | 2018-01-07 | Docetaxel 75mg/m2 (21 day) | 02 | N | 330019637 | DOCETAXEL |
| 330008549 | 330008910 | null | 90 | Curative (C) | 2015-07-23 | 2015-11-05 | EW EuroEwing 99 : VIDE | N | null | 330019639 | EURO-EWING |
| 330008550 | 330005342 | 1.73 | 75.2 | Palliative (P) | 2017-11-15 | 2017-12-02 | Cyclophosphamide + Dex + Rituximab | N | null | 330019654 | CISPLATIN + DOXORUBICIN |
| 330008551 | 330005344 | 1.75 | 65.5 | Curative (C) | 2015-10-28 | 2015-11-19 | NIVOLUMAB | N | N | 330019666 | CISPLATIN + DOXORUBICIN |
| 330008552 | 330005345 | 1.72 | 82.8 | Curative (C) | null | 2013-12-14 | Methotrexate Intrathecal (any age) | null | null | 330019674 | METHOTREXATE INTRATHECAL |
| 330008553 | 330005347 | 1.24 | 63.5 | Palliative (P) | 2014-10-18 | 2014-12-11 | Cyclophosphamide + Topotecan | N | null | 330019675 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 330008554 | 330005350 | 1.64 | 61.2 | Curative (C) | null | 2017-01-24 | Trabectedin | null | null | 330019675 | TRABECTEDIN |
| 330008555 | 330005353 | 1.8 | 106 | Curative (C) | 2016-10-29 | 2016-10-29 | LIPOSOMAL DOXORUBICIN | N | N | 330019695 | LIPOSOMAL DOXORUBICIN |
| 330008556 | 330005354 | 1.65 | 61 | Disease modification (D) | 2016-01-01 | 2016-01-02 | DA 3+8 | N | N | 330019697 | CAV |
| 330008557 | 330005354 | 0 | 63 | Adjuvant (A) | 2017-03-22 | 2017-10-07 | Cytarabine High Dose | N | N | 330019697 | CYTARABINE HIGH DOSE |
| 330008559 | 330005356 | 1.73 | 78 | Palliative (P) | 2015-02-27 | 2015-03-04 | Trabectedin | 02 | N | 330019708 | TRABECTEDIN |
| 330008560 | 330005356 | 1.71 | 72.8 | Disease modification (D) | 2017-01-17 | 2017-01-24 | Etoposide oral | 02 | N | 330019708 | ETOPOSIDE |
| 330008561 | 330011899 | 1.81 | 64.5 | Palliative (P) | 2018-01-29 | 2018-01-29 | Irinotecan + Temozolomide | 2 | N | 330019721 | IRINOTECAN + TEMOZOLOMIDE |
| 330008563 | 330008920 | 1.55 | 8.3 | Adjuvant (A) | 2013-10-10 | 2013-10-16 | VAC | 2 | N | 330019748 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 330008564 | 330005358 | 1.6 | null | Palliative (P) | 2015-09-18 | 2015-09-18 | EW Rel rEECur Irinotecan/Temozolomide | N | N | 330019771 | IRINOTECAN + TEMOZOLOMIDE |
| 330008565 | 330005362 | null | 80 | Palliative (P) | 2016-04-29 | 2016-04-29 | Methotrexate intrathecal | N | N | 330019776 | METHOTREXATE INTRATHECAL |
| 330008566 | 330005362 | 1.69 | 69.8 | Palliative (P) | 2013-05-24 | 2013-06-14 | CNS Low Grade Glioma Vinblastine | N | N | 330019776 | AZACITIDINE |
| 330008567 | 330005367 | 1.7 | 63.5 | Palliative (P) | 2015-10-12 | 2015-10-17 | Liposomal Doxorubicin (Caelyx) | 02 | N | 330019784 | LIPOSOMAL DOXORUBICIN |
| 330008568 | 330005368 | 1.64 | 102 | Curative (C) | 2017-09-10 | 2017-09-13 | FLAG + Idarubicin | 2 | N | 330019806 | FLAG + IDARUBICIN |
| 330008569 | 330010838 | null | 46.8 | Palliative (P) | 2014-05-15 | 2014-08-21 | Cisplatin + Doxorubicin | N | N | 330019806 | CISPLATIN + ETOPOSIDE |
| 330008571 | 330005373 | 1.72 | 102.9 | Palliative (P) | 2017-12-18 | 2018-01-14 | STS Rhabdomyosarcoma RMS 2005 IVADo | N | N | 330019854 | CARBOPLATIN + DOXORUBICIN |
| 330008572 | 330005373 | null | 50.6 | Neo-adjuvant (N) | null | 2016-04-26 | DHAP | 02 | null | 330019854 | IVA |
| 330008573 | 330005375 | 1.61 | null | Palliative (P) | 2013-10-24 | 2013-10-24 | Midostaurin | null | N | 330019906 | CYCLOPHOSPHAMIDE + VINCRISTINE |
| 330008574 | 330005381 | 1.79 | 70.6 | Curative (C) | 2013-09-26 | 2013-10-17 | MABCUTE TRIAL | N | N | 330019913 | BEVACIZUMAB + IRINOTECAN |
| 330008575 | 330005382 | 0 | 52.8 | Adjuvant (A) | 2017-08-02 | 2017-08-27 | LEAM | 02 | N | 330019916 | DACTINOMYCIN |
| 330008576 | 330008930 | null | 58 | Curative (C) | null | 2013-09-07 | Cisplatin + Paclitaxel | Y | N | 330019921 | EMA/CO |
| 330008577 | 330005383 | 1.86 | null | Palliative (P) | 2014-12-20 | 2015-01-15 | IVADo | 02 | N | 330019921 | DOXORUBICIN + HD MTX |
| 330008578 | 330012512 | 1.81 | null | Curative (C) | 2017-01-19 | 2017-01-19 | IBRUTINIB | 02 | N | 330019928 | AML18 TRIAL |